Outbreak of blaOXA-72-producing Acinetobacter baumannii in South America

Journal of Chemotherapy

Volumn 29, Issue 5, 2017, Pages 321-324

  Nuñez Quezada, Tamara ^a   Rodríguez, Carlos Hernan ^b   Castro Cañarte, Glenda ^c   Nastro, Marcela ^b   Balderrama Yarhui, Nora ^b   Dabos, Laura ^b   Acosta Mosquera, Yessenia ^a   Plaza Moreira, Natasha ^a   Famiglietti, Angela ^b  

^a Hospital IESS Teodoro Maldonando Carbo   (Ecuador)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c Hospital de Infectología José Daniel Rodríguez Maridueña   (Ecuador)

Author keywords

Acinetobacter baumannii; America; Carbapenem resistance; OXA 72; OXA type lactamase

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER INFECTION; ARTICLE; BACTERIUM ISOLATION; BIOLOGICAL ACCIDENT; DNA SEQUENCE; ECUADOR; GENE MAPPING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; RISK FACTOR; SOUTH AMERICA; ACINETOBACTER BAUMANNII; ADULT; AGED; BACTERIAL GENE; DRUG EFFECT; EPIDEMIC; GENETICS; HOSPITAL; HUMAN; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PROCEDURES; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DISEASE OUTBREAKS; GENES, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; SOUTH AMERICA;

EID: 84978523962     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1080/1120009X.2016.1158936     Document Type: Article

References (19)

1. Evans B, Amyes S. OXA β -lactamases. Clin Microbiol Rev. 2014;27:241–63.10.1128/CMR.00117-13
2. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother. 2010;54:24–38.10.1128/AAC.01512-08
3. Lu P-L, Doumith M, Livermore DM, Chen TP, Woodford N. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother. 2009;63:641–7.10.1093/jac/dkn553
4. Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother. 2007;51:4022–8.10.1128/AAC.01259-06
5. Lee K, Kim MN, Choi TY, Cho SE, Lee S, Whang DH, et al. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents. 2009;33:520–4.10.1016/j.ijantimicag.2008.10.009
6. Barnaud G, Zihoune N, Ricard JD, Hippeaux MC, Eveillard M, Dreyfuss D, et al. Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. J Hosp Infect. 2010;76:358–60.10.1016/j.jhin.2010.05.026
7. Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin Microbiol Infect. 2010;17:197–201.
8. Werneck JS, Picao RC, Carvalhaes CG, Cardoso JP, Gales AC. OXA-72-producing Acinetobacter baumannii Brazil: a case report. J Antimicrob Chemother. 2011;66:452–4.10.1093/jac/dkq462
9. Tian GB, Adams-Haduch JM, Bogdanovich T. Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pensylvania. Antimicrob Agents Chemother. 2011;55:429–32.10.1128/AAC.01155-10
10. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 2009;155:2333–41.10.1099/mic.0.026054-0
11. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 23nd Informational Supplement, M100–S23. Wayne (PA): Clinical Laboratory Standards Institute; 2013.
12. Woodford N, Ellington M, Coelho J, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27:351–3.10.1016/j.ijantimicag.2006.01.004
13. Quelle LS, Catalano M. Efficacy of two DNA fingerprinting methods for typing Acinetobacter baumannii isolates. Diagn Microbiol Infect Dis. 2001;39:215–23.10.1016/S0732-8893(01)00238-3
14. Opazo A, Domínguez M, Bello H, Amyes SG, Gonzalez-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Coutries. 2012;6:311–6.
15. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53:5035–8.10.1128/AAC.00856-09
16. Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother. 2006;50:2941–5.10.1128/AAC.00116-06
17. Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRYAntimicrobial Surveillance Program (Latin America, 2008–2010). Diagn Microbiol Infect Dis. 2012;73:354–60.10.1016/j.diagmicrobio.2012.04.007
18. Montealegre MC, Maya JJ, Correa A, Espinal P, Mojica MF, Ruiz SJ, et al. First identification of OXA-72 carbapenemase from Acinetobacter pitti in Colombia. Antimicrob Agents Chemother. 2012;56:3996–8.10.1128/AAC.05628-11
19. Zurita Jeanette. Informe anual de la red de monitoreo / vigilancia de la resistencia a los antibióticos–2008 [annual report of the network for monitoring/surveillance of antibiotic resistance–2008]. Revista de Patología Tropical. 2011;40:45–50.